Accessibility: Skip TopNav
Figure 1
ENTR-601-45 showed robust exon skipping and dystrophin production in vitro in patient-derived skeletal and cardiac muscle cells
Format
JPEG
Source
Entrada Therapeutics, Inc.
Downloads
Original
Large
Medium
Small